Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 151 - 175 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▼ References
DOID:1574 alcohol use disorder RGD:61800 Rattus norvegicus (Norway rat) 29595 Htr2a mutant phenotype evidence used in manual assertion
  • PMID:9631953
DOID:5844 myocardial infarction RGD:3249 Rattus norvegicus (Norway rat) 24617 Serpine1 mutant phenotype evidence used in manual assertion
  • PMID:16053971
DOID:4783 mesangial proliferative glomerulonephritis RGD:621880 Rattus norvegicus (Norway rat) 66018 Pdgfd mutant phenotype evidence used in manual assertion
  • PMID:17308324
DOID:809 cocaine abuse WB:WBGene00003386 Caenorhabditis elegans 179269 mod-1 mutant phenotype evidence used in manual assertion
  • PMID:19536276
DOID:11394 adult respiratory distress syndrome RGD:620537 Rattus norvegicus (Norway rat) 84007 C3ar1 mutant phenotype evidence used in manual assertion
  • PMID:16782534
DOID:3717 gastric adenocarcinoma HGNC:16806 Homo sapiens (human) 51366 UBR5 mutant phenotype evidence used in manual assertion
  • PMID:27590582
DOID:900 hepatopulmonary syndrome RGD:3876 Rattus norvegicus (Norway rat) 24835 Tnf mutant phenotype evidence used in manual assertion
  • PMID:26236934
DOID:11054 urinary bladder cancer HGNC:9077 Homo sapiens (human) 5347 PLK1 mutant phenotype evidence used in manual assertion
  • PMID:15761500
DOID:3910 lung adenocarcinoma HGNC:9896 Homo sapiens (human) 8241 RBM10 mutant phenotype evidence used in manual assertion
  • PMID:30955253
DOID:10588 adrenoleukodystrophy SGD:S000001671 Saccharomyces cerevisiae S288C 853647 PXA2 mutant phenotype evidence used in manual assertion
  • PMID:8876235
DOID:2526 prostate adenocarcinoma HGNC:9829 Homo sapiens (human) 5894 RAF1 mutant phenotype evidence used in manual assertion
  • PMID:15754006
DOID:14250 Down syndrome WB:WBGene00010757 Caenorhabditis elegans 259529 pad-2 mutant phenotype evidence used in manual assertion
  • PMID:15233996
DOID:1793 pancreatic cancer HGNC:6014 Homo sapiens (human) 3565 IL4 mutant phenotype evidence used in manual assertion
  • PMID:12097255
DOID:9352 type 2 diabetes mellitus WB:WBGene00001650 Caenorhabditis elegans 177850 gon-1 mutant phenotype evidence used in manual assertion
  • PMID:26218657
DOID:1064 cystinosis HGNC:2518 Homo sapiens (human) 1497 CTNS mutant phenotype evidence used in manual assertion
  • PMID:18578013
DOID:2945 severe acute respiratory syndrome HGNC:13557 Homo sapiens (human) 59272 ACE2 mutant phenotype evidence used in manual assertion
  • PMID:17974127
  • PMID:32553273
DOID:5082 liver cirrhosis RGD:3870 Rattus norvegicus (Norway rat) 29260 Tlr4 mutant phenotype evidence used in manual assertion
  • PMID:32626927
DOID:5041 esophageal cancer HGNC:9588 Homo sapiens (human) 5728 PTEN mutant phenotype evidence used in manual assertion
  • PMID:20378992
DOID:9675 pulmonary emphysema RGD:2535 Rattus norvegicus (Norway rat) 24326 Ednra mutant phenotype evidence used in manual assertion
  • PMID:19897563
DOID:12387 nephrogenic diabetes insipidus HGNC:634 Homo sapiens (human) 359 AQP2 mutant phenotype evidence used in manual assertion
  • PMID:18653713
DOID:10763 hypertension HGNC:12680 Homo sapiens (human) 7422 VEGFA mutant phenotype evidence used in manual assertion
  • PMID:20630084
DOID:3649 pyruvate decarboxylase deficiency RGD:3286 Rattus norvegicus (Norway rat) 29554 Pdha1 mutant phenotype evidence used in manual assertion
  • PMID:20685142
DOID:9970 obesity RGD:3870 Rattus norvegicus (Norway rat) 29260 Tlr4 mutant phenotype evidence used in manual assertion
  • PMID:19144836
DOID:10283 prostate cancer HGNC:2665 Homo sapiens (human) 1604 CD55 mutant phenotype evidence used in manual assertion
  • PMID:16533428
DOID:4989 pancreatitis HGNC:10618 Homo sapiens (human) 6347 CCL2 mutant phenotype evidence used in manual assertion
  • PMID:16284287
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025